Pharmaceutical companies:
Improve your patient support program
Looking for a better patient experience that drives brand performance?
AllazoHealth’s artificial intelligence engine accurately predicts patient non-adherence. The result: personalized engagements that deliver increased persistence and better patient outcomes for pharmaceutical companies.
By targeting individual patients based on their historical behavior and unique attributes, the AllazoHealth AI engine predicts the most effective engagement, personalized by channel, content, and timing.
And our artificial intelligence engine gets smarter over time, so your patient support program will continuously improve and deliver more value.
Benefits of AI-powered patient engagement
Supports patient health
Optimizes patient experience
Promotes brand loyalty
Learn how AllazoHealth used AI to optimize patient engagement in a leading pharmaceutical company’s patient support program.
Trending: COVID-19 accelerates healthcare tech
Chronic disease patients benefit from telehealth pilot With COVID-19 closing physicians’ offices and preventing patients from in-person appointments, healthcare organizations have substantially increased use of…
Pharma and physician partnerships: Overcoming barriers
Pharmaceutical companies have aspired to make medication adherence programs more effective for years. A report from Credit Suisse shows that increased adherence could substantially increase…
Implementing KPIs to track adherence progess towards brand goals
Are you measuring what matters most for your brand? Many key performance indicators (KPIs) are used to measure the success of adherence programs, and they…